Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants fast track designation to mirvetuximab soravtansine in platinum-resistant ovarian cancer

June 19, 2018

Forge Therapeutics LpxC inhibitor shows activity in vitro, in vivo and in combination

June 19, 2018

Phase II results for talimogene laherparepvec plus pembrolizumab in patients with sarcoma

June 19, 2018

Safety run-in results presented from phase III ANDROMEDA study on daratumumab

June 19, 2018

Amgen initiates phase I trial of AMG-119 in small cell lung cancer

June 19, 2018

FDA issues complete response letter for Duobrii lotion

June 19, 2018

Brain sleepiness signature, links to memory identified

June 19, 2018

Phase Ib/IIa data for a small-molecule BET inhibitor PLX-51107

June 18, 2018

Idorsia starts phase III REACT study with clazosentan

June 18, 2018

Evotec and Sanofi sign agreement in infectious diseases

June 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...